Skip to main content
Log in

Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a japanese multi-centre study

  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

In 1994, the Ministry of Health and Welfare of Japan approved photodynamic therapy (PDT) for the treatment of early stage lung cancer (T0 and T1), superficial oesophageal cancer, superficial early stage gastric cancer and carcinoma in situ and/or dysplasia of the cervix. The decision to do so was based on studies carried out by the PDT Research Group of the Ministry, including PDT treatment of 168 early stage central lung cancers (123 superficial lesions and 45 nodular lesions) and 32 superficial oesophageal cancers. The results presented in this article were analysed according to the extent of the lesion. Of the 123 superficial lung cancers, complete remission (CR) was obtained in 93% of 89 lesions less than 1.0 cm in diameter. Larger lesions responded less well. Complete remission was obtained in 97% of the 33 superficial oesophageal cancers, although three of six patients with lesions over 3.0 cm in diameter later died of metastatic disease. The authors believe PDT to be a suitable and effective treatment for early stage lung and oesophageal cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dougherty TJ, Laurence G, Boyle DG et al. A photoradiation in the treatment of recurrent breast cancer.J Natl Cancer Inst 1979,63:231–7

    Google Scholar 

  2. Hayata Y, Kato H, Konaka C et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer.Chest 1982,81:269–77

    PubMed  Google Scholar 

  3. Hayata Y, Kato H, Konaka C et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer.Chest 1984,86:169–77

    PubMed  Google Scholar 

  4. Hayata Y, Kato H, Konaka C et al. Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastro-intestinal tract.Semin Surg Oncol 1985,1:1–11

    PubMed  Google Scholar 

  5. Okunaka T, Kato H, Konaka C et al. Photodynamic therapy for multiple primary bronchogenic carcinoma.Cancer 1991,68:253–8

    PubMed  Google Scholar 

  6. Hayata Y, Kato H, Konaka C et al. Photodynamic therapy (PDT) in early stage lung cancer.Lung Cancer 1993,9:287–94

    Google Scholar 

  7. Edell EC, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma. A 5-year experience.Mayo Cli Proc 1987,62:8–14

    Google Scholar 

  8. Lam S, Kostashuk EC, Coy EP et al. A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small bronchogenic carcinoma.Photochem Photobiol 1987,46:893–8

    PubMed  Google Scholar 

  9. Spinelli P, Dal Fante M, Mancini A et al. Palliation of esophageal cancer: Endoscopic Laser therapy.Dis Esoph 1996,9:98–104

    Google Scholar 

  10. McCaughan JS, Williams TE, Bethel BH. Palliative of esophageal malignancy with photodynamic therapy.Ann Thorac Surg 1985,40:150–3

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayata, Y., Kato, H., Furuse, K. et al. Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a japanese multi-centre study. Laser Med Sci 11, 255–259 (1996). https://doi.org/10.1007/BF02134916

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02134916

Key words

Navigation